1. Home
  2. ASC vs STTK Comparison

ASC vs STTK Comparison

Compare ASC & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardmore Shipping Corporation

ASC

Ardmore Shipping Corporation

HOLD

Current Price

$16.78

Market Cap

677.7M

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$7.28

Market Cap

683.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASC
STTK
Founded
2010
2016
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
677.7M
683.8M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
ASC
STTK
Price
$16.78
$7.28
Analyst Decision
Strong Buy
Buy
Analyst Count
2
7
Target Price
$17.00
$10.00
AVG Volume (30 Days)
559.9K
1.2M
Earning Date
05-07-2026
05-01-2026
Dividend Yield
1.74%
N/A
EPS Growth
N/A
53.02
EPS
N/A
N/A
Revenue
N/A
$1,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.17
$0.71
52 Week High
$20.03
$8.33

Technical Indicators

Market Signals
Indicator
ASC
STTK
Relative Strength Index (RSI) 55.43 53.08
Support Level $15.04 $5.87
Resistance Level $17.96 $7.69
Average True Range (ATR) 0.63 0.59
MACD 0.08 -0.02
Stochastic Oscillator 68.47 43.48

Price Performance

Historical Comparison
ASC
STTK

About ASC Ardmore Shipping Corporation

Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The company markets its services directly to its customers and commercial pool operators and charters its vessels to them through a combination of spot, commercial pooling, and time-charter arrangements. The majority of its revenue is generated from spot voyages, which typically last less than three months.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: